Table 3: New cases of irritable bowel syndrome presented at follow-up. N = 166. |
||||
|
Months |
|||
1 |
3 |
6 |
12 |
|
Patients undergoing laparoscopic cholecystectomy |
||||
Postcholecystectomy syndrome |
8* |
0 |
0 |
0 |
IBS-D |
0 |
6 |
6 |
6‡ |
IBS-C |
0 |
0 |
0 |
0 |
IBS-M |
0 |
0 |
0 |
0 |
|
Remaining healthy = 160 |
Total = 6 |
||
Control patients |
|
|
|
|
IBS-D |
0 |
0 |
1 |
1‡ |
IBS-C |
0 |
0 |
0 |
0 |
IBS-M |
0 |
1 |
1 |
1‡ |
Total |
Remaining healthy = 164 |
Total = 2 |
||
* For post cholecystectomy syndrome, a separate analysis is performed; cases of this syndrome presented rapidly and were self-limited also quickly. ‡ The patients who presented irritable bowel syndrome were different from those who presented post cholecystectomy syndrome. Patients with a previous diagnosis of irritable bowel syndrome were not included in the analysis. For descriptive purposes, they continued with the same symptoms after laparoscopic cholecystectomy. IBS = irritable bowel syndrome, IBS-D = irritable bowel syndrome subtype diarrhea, IBS-C = irritable bowel syndrome subtype constipation, IBS-M = irritable bowel syndrome subtype mixed. |